High density lipoproteins improve insulin sensitivity in high-fat diet-fed mice by suppressing hepatic inflammation

Journal of Lipid Research

Volumn 55, Issue 3, 2014, Pages 421-430

  McGrath, Kristine C ^a,b   Li, Xiao Hong ^b,c   Whitworth, Phillippa T ^a   Kasz, Robert ^a   Tan, Joanne T ^b   McLennan, Susan V ^d   Celermajer, David S ^b,d,e   Barter, Philip J ^b,f   Rye, Kerry Anne ^b,f   Heather, Alison K ^a,b  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^b HEART RESEARCH INSTITUTE   (Australia)

^c Dezhou People's Hospital   (China)

^d UNIVERSITY OF SYDNEY   (Australia)

^e ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; CARBOHYDRATE RESPONSIVE ELEMENT BINDING PROTEIN; GAMMA INTERFERON; GLUCOSE; HIGH DENSITY LIPOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; RECOMBINANT HIGH DENSITY LIPOPROTEIN; REGULATOR PROTEIN; SALICYLIC ACID; SERUM AMYLOID A; SERUM AMYLOID A1; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; GENE EXPRESSION; GLUCOSE TOLERANCE; HEPATITIS; HUMAN; HUMAN CELL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; LIVER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

APOLIPOPROTEIN AI; CELLULAR SIGNALLING; INSULIN RESISTANCE;

ANIMALS; APOLIPOPROTEIN A-I; BLOOD GLUCOSE; CELL LINE, TUMOR; DIET, HIGH-FAT; GENE EXPRESSION; GLUCOSE; GLUCOSE TOLERANCE TEST; HEPATITIS, ANIMAL; HUMANS; INSULIN; INSULIN RESISTANCE; INTERFERON-GAMMA; INTERLEUKIN-6; LIPOPROTEINS, HDL; LIVER; MALE; MICE; MICE, INBRED C57BL; NF-KAPPA B; PHOSPHOENOLPYRUVATE CARBOXYKINASE (ATP); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84894842708     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M043281     Document Type: Article

References (34)

1. Shoelson, S. E., J. Lee, and A. B. Goldfine. 2006. Inflammation and insulin resistance. J. Clin. Invest. 116: 1793-1801. (Pubitemid 44033299)
2. Muriel, P. 2009. NF-kB in liver diseases: a target for drug therapy. J. Appl. Toxicol. 29: 91-100.
3. Lawrence, T. 2009. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb. Perspect. Biol. 1: a001651.
4. Cai, D., M. Yuan, D. F. Frantz, P. A. Melendez, L. Hansen, J. Lee, and S. E. Shoelson. 2005. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat. Med. 11: 183-190. (Pubitemid 40321354)
5. Hotamisligil, G. S. 2003. Inflammatory pathways and insulin action. Int. J. Obes. Relat. Metab. Disord. 27 (Suppl 3): S53-S55. (Pubitemid 38019190)
6. Karin, M., and M. Delhase. 2000. The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Semin. Immunol. 12: 85-98. (Pubitemid 30114019)
7. Hayden, M. S., and S. Ghosh. 2004. Signaling to NF-kappaB. Genes Dev. 18: 2195-2224.
8. Baeuerle, P. A., and D. Baltimore. 1988. I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science. 242: 540-546. (Pubitemid 18263193)
9. Ghosh, S., and D. Baltimore. 1990. Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B. Nature. 344: 678-682.
10. Nicholls, S. J., G. J. Dusting, B. Cutri, S. Bao, G. R. Drummond, K. A. Rye, and P. J. Barter. 2005. Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits. Circulation. 111: 1543-1550. (Pubitemid 40470651)
11. Murthy, S. N., C. V. Desouza, N. W. Bost, R-C. St. Hilaire, D. B. Casey, A. M. Badejo, J. S. Dhaliwal, J. McGee, D. B. McNamara, P. J. Kadowitz, et al. 2010. Effects of salsalate therapy on recovery from vascular injury in female Zucker fatty rats. Diabetes. 59: 3240-3246.
12. McGrath, K. C., X. H. Li, R. Puranik, E. C. Liong, J. T. Tan, V. M. Dy, B. A. DiBartolo, P. J. Barter, K. A. Rye, and A. K. Heather. 2009. Role of 3beta-hydroxysteroid-delta 24 reductase in mediating antiinflammatory effects of high-density lipoproteins in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 29: 877-882.
13. Karhapää, P., M. Malkki, and M. Laakso. 1994. Isolated low HDL cholesterol. An insulin-resistant state. Diabetes. 43: 411-417. (Pubitemid 24064248)
14. Weisweiler, P. 1987. Isolation and quantitation of apolipoproteins A-I and A-II from human high-density lipoproteins by fast-protein liquid chromatograph y. Clinica chimica acta; international journal of clinical chemistry. 169: 249-54.
15. Matz, C. E., and A. Jonas. 1982. Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions. J. Biol. Chem. 257: 4535-4540.
16. Ramírez-Zacarías, J. L., F. Castro-Muñozledo, and W. Kuri-Harcuch. 1992. Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O. Histochemistry. 97: 493-497.
17. Dean, R. T., W. Hylton, and A. C. Allison. 1979. Induction of macrophage lysosomal enzyme secretion by agents acting on the plasma membrane. Exp. Cell Biol. 47: 454-462. (Pubitemid 10157795)
18. Death, A. K., K. C. Y. McGrath, M. A. Sader, S. Nakhla, W. Jessup, D. J. Handelsman, and D. S. Celermajer. 2004. Dihydrotestosterone promotes vascular cell adhesion molecule-1 expression in male human endothelial cells via a nuclear factor-kappaB-dependent pathway. Endocrinology. 145: 1889-1897. (Pubitemid 38402398)
19. Bustin, S. A. 2000. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J. Mol. Endocrinol. 25: 169-193.
20. Pahl, H. L. 1999. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene. 18: 6853-6866.
21. Oeckinghaus, A., and S. Ghosh. 2009. The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb. Perspect. Biol. 1: a000034.
22. Kopp, E., and S. Ghosh. 1994. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science. 265: 956-959.
23. Arkan, M. C., A. L. Hevener, F. R. Greten, S. Maeda, Z. W. Li, J. M. Long, A. Wynshaw-Boris, G. Poli, J. Olefsky, and M. Karin. 2005. IKK-beta links inflammation to obesity-induced insulin resistance. Nat. Med. 11: 191-198. (Pubitemid 40321355)
24. Reimers, G. J., C. L. Jackson, J. Rickards, P. Y. Chan, J. S. Cohn, K-A. Rye, P. J. Barter, and K. J. Rodgers. 2011. Inhibition of rupture of established atherosclerotic plaques by treatment with apolipoprotein A-I. Cardiovasc. Res. 91: 37-44.
25. Yvan-Charvet, L., C. Welch, T. A. Pagler, M. Ranalletta, M. Lamkanfi, S. Han, M. Ishibashi, R. Li, N. Wang, and A. R. Tall. 2008. Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions. Circulation. 118: 1837-1847.
26. Sun, Y., M. Ishibashi, T. Seimon, M. Lee, S. M. Sharma, K. A. Fitzgerald, A. O. Samokhin, Y. Wang, S. Sayers, M. Aikawa, et al. 2009. Free cholesterol accumulation in macrophage membranes activates Toll-like receptors and p38 mitogen-activated protein kinase and induces cathepsin K. Circ. Res. 104: 455-465.
27. Murphy, A. J., K. J. Woollard, A. Hoang, N. Mukhamedova, R. A. Stirzaker, S. P. McCormick, A. T. Remaley, D. Sviridov, and J. Chin-Dusting. 2008. High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler. Thromb. Vasc. Biol. 28: 2071-2077.
28. Fryirs, M. A., P. J. Barter, M. Appavoo, B. E. Tuch, F. Tabet, A. K. Heather, and K. A. Rye. 2010. Effects of high-density lipoproteins on pancreatic beta-cell insulin secretion. Arterioscler. Thromb. Vasc. Biol. 30: 1642-1648.
29. Drew, B. G., S. J. Duffy, M. F. Formosa, A. K. Natoli, D. C. Henstridge, S. A. Penfold, W. G. Thomas, N. Mukhamedova, B. de Courten, J. M. Forbes, et al. 2009. High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus. Circulation. 119: 2103-2111.
30. Umemoto, T., C. Y. Han, P. Mitra, M. M. Averill, C. Tang, L. Goodspeed, M. Omer, S. Subramanian, S. Wang, L. J. Den Hartigh, et al. 2013. Apolipoprotein AI and high-density lipoprotein have anti-inflammatory effects on adipocytes via cholesterol transporters: ATP-binding cassette A-1, ATP-binding cassette G-1, and scavenger receptor B-1. Circ. Res. 112: 1345-1354.
31. Ruan, X., Z. Li, Y. Zhang, L. Yang, Y. Pan, Z. Wang, G-S. Feng, and Y. Chen. 2011. Apolipoprotein A-I possesses an anti-obesity effect associated with increase of energy expenditure and up-regulation of UCP1 in brown fat. J. Cell. Mol. Med. 15: 763-772.
32. Barter, P. J., K-A. Rye, J-C. Tardif, D. D. Waters, S. M. Boekholdt, A. Breazna, and J. J. P. Kastelein. 2011. Effect of torcetrapib on glucose, insulin, and hemoglobin A1c in subjects in the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) trial. Circulation. 124: 555-562.
33. Goldfine, A. B., V. Fonseca, K. A. Jablonski, L. Pyle, M. A. Staten, S. E. Shoelson; TINSAL-T2D (Targeting Inflammation Using Salsalate in Type 2 Diabetes) Study Team. 2010. The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Ann. Intern. Med. 152: 346-357.
34. Tai, E. S., S. C. Emmanuel, S. K. Chew, B. Y. Tan, and C. E. Tan. 1999. Isolated low HDL cholesterol: an insulin-resistant state only in the presence of fasting hypertriglyceridemia. Diabetes. 48: 1088-1092.